1.Causes of mortality in patients with psoriasis in Malaysia –Evidence from the Malaysian Psoriasis Registry
Zhenli Kwan ; Chin Aun Yeoh ; Azura Mohd Affandi ; Fatimah Afifah Alias ; Muneer Hamid ; Nurakmal Baharum ; Adrian Sze Wai Yong ; Roshidah Baba
The Medical Journal of Malaysia 2015;70(5):273-277
Background: Patients with severe psoriasis, namely those
requiring phototherapy or systemic treatment, have an
increased risk of death. The aim of this study was to
determine the prevalence, aetiology and risk factors for
mortality among adult patients aged 18 years and above with
psoriasis in Malaysia.
Methods: This was a retrospective study involving adult
patients notified by dermatologists to the Malaysian
Psoriasis Registry between July 2007 and December 2013.
Data were cross-checked against the National Death
Registry. Patients certified dead were identified and the
cause of death was analysed. Multivariate analysis using
multiple logistic regression were conducted on potential
factors associated with higher risk of mortality.
Results: A total of 419 deaths were identified among the
9775 patients notified. There were four significant risk
factors for higher mortality: age>40 years (age 41-60 years
old, Odds Ratio (OR) 2.70, 95%CI 1.75, 4.18; age>60 years
OR 7.46, 95%CI 4.62, 12.02), male gender (OR 1.72, 95%CI
1.33,2.22), severe psoriasis with body surface area (BSA)
>10% (OR 1.52, 95%CI 1.19, 1.96) and presence of at least
one cardiovascular co-morbidity (OR 1.67, 95% CI 1.30,
2.14). Among the 301 patients with verifiable causes of
death, the leading causes were infection (33.9%),
cardiovascular disease (33.6%) and malignancy (15.9%).
Conclusion: Infection was the leading cause of death among
psoriasis patients in Malaysia. Although cardiovascular
diseases are well-known to cause significant morbidity and
mortality among psoriasis patients, the role of infections
and malignancy should not be overlooked.
Psoriasis
2.Prevalence and risk factors of genitourinary Chlamydia trachomatis infection among patients attending sexually transmitted disease clinics in northern Malaysia
Chin Aun Yeoh ; Lee Chin Chan ; Chin Chin Ch&rsquo ; ng ; Wooi Chiang Tan
The Medical Journal of Malaysia 2020;75(2):103-109
Chlamydia trachomatis; sexually transmitted disease; prevalence;infection
Introduction: Chlamydia trachomatis is one of the most
common sexually transmitted diseases (STDs) globally.
However, data on its prevalence and risk factors in Malaysia
is still scarce.
Objective: We aimed to identify the prevalence and risk
factors of genitourinary C.trachomatis infection among
patients attending STD clinics in northern Peninsular
Malaysia.
Methods: A hospital-based cross-sectional study was
conducted in STD clinics of Hospital Pulau Pinang and
Hospital Sultanah Bahiyah, Kedah from January to
November 2014. Participants were individually interviewed
using a structured data collection form followed by a
physical examination and laboratory tests. Nucleic Acid
Amplification Test (NAAT) was used to detect C.trachomatis
infection. Analysis was carried out using SPSS Version 15.
Results: Eighty-three sexually active patients were enrolled,
consisting of 51 males and 32 females. The median age was
28.0 years. In general, 32.5% patients were asymptomatic,
the remaining presented with genital discharge (41.0%),
genital warty lesion (25.3%), genital ulcer (13.3%), dysuria
(13.3%), dyspareunia (2.4%), urine hesistancy (1.2%) and
genital swelling (1.2%). The prevalence of genitourinary
C.trachomatis infection was 21.7% in the study population;
17.6% in males and 28.1% in females. Among the infected
females, 44.4% were pregnant. Of those infected 56.6% did
not show any symptoms of genital infection, and 77.8% were
aged between 18 and 30 years, of which most were females.
Among newly diagnosed HIV patients, the prevalence was
14.3%. From multivariable logistic regression analysis, age
under 28 years, being married and engagement in oral sex
had significantly increased odds of C.trachomatis infection.
Conclusions: C.trachomatis infection was common among
patients attending STD clinics in northern Penisular
Malaysia especially in the younger age groups. Majority of
the infected patients were asymptomatic.
3.Human Immunodeficiency Virus-infected men who have sex with men with syphilis: A 5-year multicentre study in Malaysia
Siaw Yen Ong ; Min Moon Tang ; Izzaty Dalawi ; Wooi Chiang Tan ; Chin Aun Yeoh ; Wee Meng Kho ; Pubalan Muniandy ; Pui Li Wong ; Rukumani Devi Velayuthan ; Zhenli Kwan ; Chin Chwen Ch&rsquo ; ng ; Norli Marwyne Mohd Noor ; Vijayaletchumi Krishnasamy ; Asmah Johar
The Medical Journal of Malaysia 2020;75(4):349-355
Objectives: High rates of syphilis have been reported
worldwide among men who have sex with men (MSM). This
study aims to describe the clinical pattern and treatment
response of syphilis among human immunodeficiency virus
(HIV)-infected MSM in Malaysia.
Methods: This is a retrospective study on all HIV-infected
MSM with syphilis between 2011 and 2015. Data was collected
from case notes in five centres namely Hospital Kuala Lumpur,
Hospital Sultanah Bahiyah, Hospital Umum Sarawak,
University of Malaya Medical Centre and Hospital Sungai
Buloh.
Results: A total of 294 HIV seropositive MSM with the median
age of 29 years (range 16-66) were confirmed to have syphilis.
Nearly half (47.6%) were in the age group of 20-29 years.
About a quarter (24.1%) was previously infected with syphilis.
Eighty-three patients (28.2%) had other concomitant sexually
transmitted infection with genital warts being the most
frequently reported (17%). The number of patients with early
and late syphilis in our cohort were almost equal. The median
pre-treatment non-treponemal antibody titre (VDRL or RPR)
for early syphilis (1:64) was significantly higher than for late
syphilis (1:8) (p<0.0001). The median CD4 count and the
number of patients with CD4 <200/μl in early syphilis were
comparable to late syphilis. Nearly four-fifth (78.9%) received
benzathine-penicillin only, 5.8% doxycycline, 1.4% Cpenicillin, 1% procaine penicillin, and 12.4% a combination of
the above medications. About 44% received treatment and
were lost to follow-up. Among those who completed 1 -year
follow-up after treatment, 72.3% responded to treatment
(serological non-reactive – 18.2%, four-fold drop in titre –
10.9%; serofast – 43.6%), 8.5% failed treatment and 17% had
re-infection. Excluding those who were re-infected, lost to
follow-up and died, the rates of treatment failure were 12.1%
and 8.8% for early and late syphilis respectively (p=0.582) Conclusion: The most common stage of syphilis among MSM
with HIV was latent syphilis. Overall, about 8.5% failed
treatment at 1-year follow-up.